SC
LUMO

Steven Cohen’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Steven Cohen’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,853
Closed -$1.82M – 1125
2017
Q3 		$1.82M Buy
+19,853
New +$1.52M 0.01% 690
2017
Q2 		– Sell
-4,444
Closed -$964K – 1037
2017
Q1 		$964K Buy
+4,444
New +$635K 0.01% 739

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steven Cohen's LUMO Position: Q4 2017 in Review

Steven Cohen sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2017, closing a stake of 19,853 shares — an estimated $1.82M sold.

Steven Cohen first reported a position in LUMO in Q1 2017 and held it in 2 quarters. The position peaked at $1.82M in Q3 2017. 130 funds tracked by Wall St. Rank hold LUMO as of Q4 2017.

  • Steven Cohen reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Steven Cohen sold 19,853 Lumos Pharma, Inc. Common Stock shares in Q4 2017, an estimated $1.82M.
  • Steven Cohen first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Steven Cohen's Lumos Pharma, Inc. Common Stock position peaked at $1.82M in Q3 2017.
  • 130 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2017.

Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.